|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Georgia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing GeorgiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
CryoLife, Inc.
| | | Phone: | (770) 419-3355 | Fax: | (770) 426-0031 | Year Established: | 1984 | Ticker: | CRY | Exchange: | NYSE | Main Contact: | James Patrick (Pat) Mackin, President, CEO & Chairman | | Other Contacts: | William R. Matthews, Senior VP, Operations, Quality & Regulatory D. Ashley Lee, CPA, Executive VP, COO & CFO Amy D. Horton, CPA, VP & CAO David N. Hollinworth, Ph.D., VP & GM Jean F. Holloway, Esq., Senior VP & General Counsel Richard C. Gridley, VP, Canada, Asia Pacific & the Americas & GM John Davis, Senior VP, Global Sales & Marketing David C. Gale, Ph.D., VP, R&D
| | Company Description | CryoLife is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and Canada. The Company's CryoValve(R) SG pulmonary human heart valve, processed using CryoLife's proprietary SynerGraft(R) technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed or malfunctioning native pulmonary valves. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. BIOGLUE Aesthetic(TM) Medical Adhesive is CE marked in the European Community for periosteal fixation following endoscopic browplasty (brow lift) in reconstructive plastic surgery and is distributed by a third party for this indication. CryoLife distributes HemoStase(TM), a hemostatic agent, in much of the U.S. for use in cardiac and vascular surgery and in the European Community and Canada for cardiac, vascular, and general surgery, subject to certain exclusions. | |
|
|
|
|
|